Davide Trere
Rimini, 47921, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Circulating miR-22 Early Predicts TACE Non-Response and Targets WEE1 in Hepatocellular Carcinoma.
Journal: Cells
Published: March 10, 2026
Ribosome biogenesis rate, a parameter of sensitivity to chemotherapeutic drugs inhibiting rRNA synthesis.
Journal: Oncology reviews
Published: November 05, 2025
5.8S rRNA forms and ribosome heterogeneity in breast cancer.
Journal: Biochimie
Published: February 17, 2025
Medical students' attitude toward robotic surgery: time to revise medical school curricula?
Journal: Journal of robotic surgery
Published: January 08, 2025
Downregulation of rRNA synthesis by BCL-2 induces chemoresistance in diffuse large B cell lymphoma.
Journal: iScience
Published: August 19, 2024
Liquid Biopsy in the Management of Breast Cancer Patients: Where Are We Now and Where Are We Going.
Journal: Diagnostics (Basel, Switzerland)
Published: February 24, 2023
MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma.
Journal: Biomolecules
Published: May 18, 2022
Assessing the Role of Trust in Information Sources, Adoption of Preventive Practices, Volunteering and Degree of Training on Biological Risk Prevention, on Perceived Risk of Infection and Usage of Personal Protective Equipment Among Italian Medical Students During the SARS-CoV-2 Pandemic.
Journal: Frontiers in public health
Published: July 23, 2021
MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary.
Journal: Molecular oncology
Published: January 09, 2021
SARS-CoV-2/COVID-19 Testing: The Tower of Babel.
Journal: Acta bio-medica : Atenei Parmensis
Published: November 06, 2020
Last Updated: 09/26/2026